These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 29599284)
21. Risk of intracranial hemorrhage in patients using anticoagulant therapy for atrial fibrillation after cerebral microbleeds combined with acute ischemic stroke: a meta-analysis. Zhao B; Yuan Y; Li Z; Chen Y; Gao Y; Yang B; Wu J; Jia W Front Neurol; 2024; 15():1372231. PubMed ID: 38560733 [TBL] [Abstract][Full Text] [Related]
22. Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke. Hoyer C; Filipov A; Neumaier-Probst E; Szabo K; Ebert A; Alonso A J Thromb Thrombolysis; 2018 May; 45(4):529-535. PubMed ID: 29476304 [TBL] [Abstract][Full Text] [Related]
23. Epidemiology of cerebral microbleeds and risk of adverse outcomes in atrial fibrillation: a systematic review and meta-analysis. Corica B; Romiti GF; Raparelli V; Cangemi R; Basili S; Proietti M Europace; 2022 Oct; 24(9):1395-1403. PubMed ID: 35244694 [TBL] [Abstract][Full Text] [Related]
24. Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists. Konieczyńska M; Sobieraj E; Bryk AH; Dębski M; Polak M; Podolec P; Małecka B; Pająk A; Desteghe L; Heidbuchel H; Undas A Kardiol Pol; 2018; 76(7):1089-1096. PubMed ID: 29528483 [TBL] [Abstract][Full Text] [Related]
25. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA). Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C; Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177 [TBL] [Abstract][Full Text] [Related]
26. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy. De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115 [TBL] [Abstract][Full Text] [Related]
27. Effectiveness of Nonvitamin K Antagonist Oral Anticoagulants and Warfarin for Preventing Further Cerebral Microbleeds in Acute Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation and At Least One Microbleed: CMB-NOW Multisite Pilot Trial. Yokoyama M; Mizuma A; Terao T; Tanaka F; Nishiyama K; Hasegawa Y; Nagata E; Nogawa S; Kobayashi H; Yanagimachi N; Okazaki T; Kitagawa K; Takizawa S; J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1918-1925. PubMed ID: 31005561 [TBL] [Abstract][Full Text] [Related]
28. Medium- to long-term persistence with non-vitamin-K oral anticoagulants in patients with atrial fibrillation: Australian experience. Simons LA; Ortiz M; Freedman B; Waterhouse BJ; Colquhoun D Curr Med Res Opin; 2017 Jul; 33(7):1337-1341. PubMed ID: 28425296 [TBL] [Abstract][Full Text] [Related]
29. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP; Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380 [TBL] [Abstract][Full Text] [Related]
31. POST-NOAC: Portuguese observational study of intracranial hemorrhage on non-vitamin K antagonist oral anticoagulants. Marques-Matos C; Alves JN; Marto JP; Ribeiro JA; Monteiro A; Araújo J; Silva F; Grenho F; Viana-Baptista M; Sargento-Freitas J; Pinho J; Azevedo E Int J Stroke; 2017 Aug; 12(6):623-627. PubMed ID: 27903938 [TBL] [Abstract][Full Text] [Related]
32. Choice of New Oral Anticoagulant Agents Versus Vitamin K Antagonists in Atrial Fibrillation: FANTASIIA Study. Moreno-Arribas J; Bertomeu-González V; Anguita-Sanchez M; Cequier Á; Muñiz J; Castillo J; Sanchis J; Roldán I; Marín F; Bertomeu-Martínez V; J Cardiovasc Pharmacol Ther; 2016 Mar; 21(2):150-6. PubMed ID: 26229096 [TBL] [Abstract][Full Text] [Related]
33. Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study. Bouillon K; Bertrand M; Maura G; Blotière PO; Ricordeau P; Zureik M Lancet Haematol; 2015 Apr; 2(4):e150-9. PubMed ID: 26687957 [TBL] [Abstract][Full Text] [Related]
34. Role of cerebral microbleeds in acute ischemic stroke and atrial fibrillation. Wang M; Yang Y; Luan M; Wang Y; Zhong M; Xu L; Zheng X J Thromb Thrombolysis; 2023 Apr; 55(3):553-565. PubMed ID: 36571659 [TBL] [Abstract][Full Text] [Related]
35. New oral anticoagulants for the prevention of thromboembolic complications in atrial fibrillation: a single centre experience. Gorczyca-Michta I; Wożakowska-Kapłon B Kardiol Pol; 2015; 73(2):85-93. PubMed ID: 25179482 [TBL] [Abstract][Full Text] [Related]
36. Prior Antithrombotic Therapy Is Associated With Cerebral Microbleeds in Ischemic Stroke Patients With Atrial Fibrillation and/or Rheumatic Heart Disease. Cheng Y; Liu J; Zhang S; Li J; Wei C; Wang D; Lin J; Wang Y; Wu B; Zhang S; Liu M Front Neurol; 2018; 9():1184. PubMed ID: 30687227 [No Abstract] [Full Text] [Related]
37. Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: A trans-esophageal echocardiography study. Kim YG; Choi JI; Kim MN; Cho DH; Oh SK; Kook H; Park HS; Lee KN; Baek YS; Roh SY; Shim J; Park SM; Shim WJ; Kim YH PLoS One; 2018; 13(1):e0191648. PubMed ID: 29360845 [TBL] [Abstract][Full Text] [Related]
38. The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation. Wang J; Zhang J; Shen Y; Xu X BMC Cardiovasc Disord; 2019 Apr; 19(1):77. PubMed ID: 30940095 [TBL] [Abstract][Full Text] [Related]
39. Unanswered questions and research priorities to optimise stroke prevention in atrial fibrillation with the new oral anticoagulants. Hankey GJ Thromb Haemost; 2014 May; 111(5):808-16. PubMed ID: 24285341 [TBL] [Abstract][Full Text] [Related]
40. Cerebral Microbleeds, Vascular Risk Factors, and Magnetic Resonance Imaging Markers: The Northern Manhattan Study. Caunca MR; Del Brutto V; Gardener H; Shah N; Dequatre-Ponchelle N; Cheung YK; Elkind MS; Brown TR; Cordonnier C; Sacco RL; Wright CB J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27638784 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]